Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clot formation.

Aggrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI) or those with acute coronary syndrome. It works by inhibiting platelet aggregation, which helps maintain blood flow and reduces the risk of heart attacks or strokes. Patients may wonder, 'What is Aggrastat used for?' It is specifically designed for intravenous administration to provide rapid and effective clot prevention.

Common effects of Aggrastat may include bleeding at the injection site, bruising, or prolonged bleeding from cuts. Some patients may experience nausea, dizziness, or low blood pressure. These effects are generally mild and temporary, but any severe or persistent symptoms should be discussed with a healthcare provider.

Aggrastat should be handled with care to avoid contamination. It is important to follow proper administration procedures to minimize the risk of bleeding complications. Patients with a history of bleeding disorders or those taking other blood-thinning medications should use Aggrastat under close medical supervision.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Alcohol consumption should be avoided as it can increase the risk of bleeding. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions.